Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Glaucoma Surgery Devices Market Value Growth And Long-Term Outlook
The glaucoma surgery devices market size has experienced significant growth in recent years. It is anticipated to expand from $2.13 billion in 2025 to $2.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.6%. This historical expansion can be attributed to factors such as the increasing prevalence of glaucoma disorders, a rise in ophthalmic surgical volumes, heightened awareness regarding early glaucoma treatment, developments in eye care infrastructure, and the accessibility of advanced surgical instruments.
The glaucoma surgery devices market is projected for substantial expansion in the coming years. Its valuation is anticipated to reach $4.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.6%. This anticipated growth during the forecast timeframe is attributable to factors such as an expanding elderly demographic, the growing embrace of MIGS procedures, heightened investments in eye care innovation, an increased call for outpatient eye operations, and wider availability of advanced glaucoma treatments. Key developments expected within this period encompass the wider acceptance of minimally invasive glaucoma surgery devices, a surge in the utilization of micro-invasive glaucoma implants, the increasing incorporation of laser-based treatment technologies, the broadening of customized glaucoma treatment strategies, and a stronger emphasis on accuracy and safety in surgical procedures.
Get A Free Sample Report With In-Depth Market Insights:
Glaucoma Surgery Devices Market Growth Catalysts And Demand Drivers
An anticipated rise in glaucoma cases is set to propel expansion within the glaucoma surgery devices market. Glaucoma is a deteriorating eye condition characterized by optic nerve damage, potentially causing irreversible blindness without timely diagnosis and intervention. Instruments used in glaucoma surgery are crucial, enhancing the safety, efficacy, and minimally invasive nature of these procedures, thereby substantially fueling demand. For example, data released in May 2024 by the Centers for Disease Control and Prevention, a US-based government agency, indicates that in 2025, more than 3 million Americans suffer from glaucoma, with projections showing this figure reaching 6.3 million by 2050, primarily driven by the aging demographic in the US. Consequently, the expanding occurrence of glaucoma will propel the glaucoma surgery devices market.
Glaucoma Surgery Devices Market Segment Performance And Emerging Opportunities
The glaucoma surgery devices market covered in this report is segmented –
1) By Product: Drainage Systems, Laser-Based Devices, Implants
2) By Treatment: Open-Angle, Closed-Angle
3) By Type Of Surgery: Angle Closure Glaucoma Surgery, Aqueous Shunt Surgery, Laser Surgery
4) By Application: Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries
5) By End User: Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers
Subsegments:
1) By Drainage Systems: Tubes And Shunts, Valves
2) By Laser-Based Devices: Laser Trabeculoplasty, Laser Iridotomy Devices, Laser Cyclophotocoagulation Devices
3) By Implants: Gel Stents, Ahmed Glaucoma Valve Implants, Baerveldt Implants
Glaucoma Surgery Devices Market Trends Shaping Long-Term Demand
Major companies involved in the glaucoma surgery devices market are concentrating on developing advanced solutions, including Direct Selective Laser Trabeculoplasty (DSLT) devices, to deliver precise, non-invasive treatment for reducing intraocular pressure in patients with glaucoma. Direct Selective Laser Trabeculoplasty (DSLT) devices are sophisticated ophthalmic tools that employ targeted laser energy to treat the eye’s drainage network, thereby decreasing intraocular pressure in glaucoma patients without requiring invasive surgery. For instance, in February 2025, Alcon Inc., a Switzerland-based eye care device company, unveiled Voyager DSLT, which is the first and only Direct Selective Laser Trabeculoplasty (DSLT) device available for treating both glaucoma and ocular hypertension. Voyager DSLT functions as a fully automated system, accurately delivering 120 laser pulses to the trabecular meshwork via the limbus, utilizing advanced eye-tracking technology and eliminating the need for a gonio lens or manual aiming. This innovation improves aqueous outflow to lower intraocular pressure, simplifying the procedure for physicians and enhancing patient comfort. By offering a fast, non-contact, and comfortable treatment, the device is well-suited as a first-line therapy, potentially reducing patients’ reliance on medications while upholding a strong safety profile.
Glaucoma Surgery Devices Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the glaucoma surgery devices market are Alcon, Johnson & Johnson, Carl Zeiss Meditec AG, Bausch & Lomb, Glaukos Corporation, Sight Sciences, Iridex Corporation, Ellex Medical Lasers, Lumenis, Ziemer Ophthalmic Systems, Nidek, Topcon, BVI, Rheon Medical, New World Medical, Haag-Streit, OptoLight Vision Technology, Katalyst Surgical, Aerie Pharmaceuticals, MicroSurgical Technology, iSTAR Medical
View The Full Glaucoma Surgery Devices Market Report:
Glaucoma Surgery Devices Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the glaucoma surgery devices market in 2025. The regions covered in the glaucoma surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
